• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
APV
Click for more information
1.10% 9.0¢

APPSVILLAGE AUSTRALIA LIMITED

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
APV
the greenchip review 		01/08/08 0 322
01/08/08 Last post  CATCHBULL Comments Created with Sketch.  0  Views Created with Sketch.  322 
APV
healthy interest 		07/12/06 0 256
07/12/06 Last post  Fringedweller Comments Created with Sketch.  0  Views Created with Sketch.  256 
APV
comments please 		30/11/06 2 385
30/11/06 Last post  abeaty Comments Created with Sketch.  2  Views Created with Sketch.  385 
APV
upward trend 		26/07/06 0 314
26/07/06 Last post  Fringedweller Comments Created with Sketch.  0  Views Created with Sketch.  314 
APV
good fit 		01/07/06 0 270
01/07/06 Last post  Fringedweller Comments Created with Sketch.  0  Views Created with Sketch.  270 
APV
chart....after voip we have wimax 		13/01/06 2 422
13/01/06 Last post  trendtrading Comments Created with Sketch.  2  Views Created with Sketch.  422 
APV
wimax big winner in 2006 		13/01/06 0 290
13/01/06 Last post  trendtrading Comments Created with Sketch.  0  Views Created with Sketch.  290 
APV
access providers? 		19:27 1 292
19:27 Last post  Trader72 Comments Created with Sketch.  1  Views Created with Sketch.  292 

See All Discussions arrow Created with Sketch.

Top Stories

Banshee's historic trenches prove rich in antimony and gold for GDM

Great Divide Mining Ltd has found high-grade antimony and gold through geochemical sampling at its Banshee prospect in Queensland
InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch CuFe Ltd (ASX:CUF) has decided not to wait around for Northern Star's Crossroads mine to get up and running, selling its $4M royalty right.
NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play Empire Energy (ASX:EEG) has confirmed the NT government has delivered environmental approvals for Carpentaria.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.